| C08CA |
C08CA Dihydropyridine derivatives |
| C08CA01 |
C08CA01 amlodipine |
| C08CA02 |
C08CA02 felodipine |
| C08CA03 |
C08CA03 isradipine |
| C08CA04 |
C08CA04 Nicardipine |
| C08CA05 |
C08CA05 Nifedipine |
| C08CA06 |
C08CA06 Nimodipine |
| C08CA07 |
C08CA07 Nisoldipine |
| C08CA08 |
C08CA08 nitrendipine |
| C08CA09 |
C08CA09 lacidipine |
| C08CA10 |
C08CA10 nilvadipine |
| C08CA11 |
C08CA11 manidipine |
| C08CA12 |
C08CA12 barnidipine |
| C08CA13 |
C08CA13 lercanidipine |
| C08CA14 |
C08CA14 cilnidipine |
| C08CA15 |
C08CA15 benidipine |
| C08CA16 |
C08CA16 clevidipine |
| C08CA51 |
C08CA51 Amlodipine And Celecoxib |
| C08CA55 |
C08CA55 nifedipine, combinations |
| C08CX |
C08CX Other Selective Calcium Channel Blockers With Mainly Vascular Effects |
| C08CX01 |
C08CX01 mibefradil |
| C08D |
C08D Selective calcium channel blockers with direct cardiac effects |
| C08DA |
C08DA Phenylalkylamines derivatives |
| C08DA01 |
C08DA01 verapamil |
| C08DA02 |
C08DA02 gallopamil |
| C08DA51 |
C08DA51 verapamil, combinations |
| C08DB |
C08DB Benzothiazepines derivatives |
| C08DB01 |
C08DB01 Diltiazem |
| C08E |
C08E Non-Selective Calcium Channel Blockers |
| C08EA |
C08EA Phenylalkylamine Derivatives |